C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 77-84

  Butland, B K ^a   Strachan, D P ^a   Rudnicka, A R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Asthma; Atopy; Body mass index; C reactive protein

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ASTHMA; ATOPY; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SMOKING HABIT; WHEEZING; BLOOD; HYPERSENSITIVITY; MIDDLE AGED; RISK; SMOKING; UNITED KINGDOM;

ADULT; ASTHMA; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; GREAT BRITAIN; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; SMOKING;

EID: 52749087119     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00077207     Document Type: Article

References (26)

1. Ólafsdottir IS, Gislason T, Thjodleifsson B, et al. C-reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60: 451-454.
2. Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000; 21: 1584-1590.
3. Pinto-Plata VM, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and nonsmokers. Thorax 2006; 61: 23-28.
4. Yende S, Waterer GW, Tolley EA, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61: 10-16.
5. Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
6. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.
7. Sävykoski T, Harju T, Paldanius M, et al. Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration 2004; 71: 120-125.
8. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax 2006; 61: 1-3.
9. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004; 59: 892-896.
10. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 2006; 35: 34-41.
11. Hawkes D, Plewis I. Modelling non-response in the National Child Development Study. JR Stat Soc Ser A 2006; 169: 479-491.
12. Bynner J, Butler N, Ferri E, Shepherd P, Smith K. Working Paper 1: The Design and conduct of the 1999-2000 Surveys of the National Child Development Study and the 1970 British Cohort study. Centre for Longitudinal Studies. London, Institute of Education University of London, 2000.
13. Power C, Atherton K, Strachan DP, et al. Life-course influences on health in British adults: effects of socioeconomic position in childhood and adulthood. Int J Epidemiol 2007; 36: 532-539.
14. Fuller E, Power C, Shepherd P, Strachan DP. Technical report on the National Child Development Study biomedical survey 2002-2004. www.b58cgene.sgul.ac.uk/report.php Date last updated: February 28, 2008. Date last accessed: January 27, 2008.
15. Nolte H, DuBuske LM. Performance characteristics of a new automated enzyme immunoassay for the measurement of allergen-specific IgE: summary of the probability outcomes comparing results of allergen skin testing to results obtained with the HYTEC system and CAP system. Ann Allergy Asthma Immunol 1997; 79: 27-34.
16. Butland BK, Strachan DP. Asthma onset and relapse in adult life: the British 1958 birth cohort study. Ann Allergy Asthma Immunol 2007; 98: 337-343.
17. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007; 115: 996-1003.
18. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006; 61: 17-22.
19. Raitakari M, Mansikkaniemi K, Marniemi J, Viikari JSA, Raitakari OT. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: the cardiovascular risk in young Finns study. J Intern Med 2005; 258: 428-434.
20. Sunyer J, Antó JM, Kogevinas M, Soriano JB, Tobías A, Muñoz A. Smoking and bronchial responsiveness in non-atopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax 1997; 52: 235-238.
21. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk factor for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001; 56: 4-8.
22. Chinn S. Obesity and asthma: evidence for and against a causal relation. J Asthma 2003; 40: 1-16.
23. Bråbäck L, Hjern A, Rasmussen F. Body mass index, asthma and allergic rhinoconjunctivitis in Swedish conscripts - a national cohort study over three decades. Respir Med 2005; 99: 1010-1014.
24. Franks PW. Obesity, inflammatory markers and cardiovascular diease: distinguishing causality from confounding. J Hum Hypertens 2006; 20: 837-840.
25. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 760-765.
26. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126: Suppl. 2, 117s-124s.